This study utilized biomimetic nanovesicles loaded with PEBP1 mRNA to activate the NRF2/GPX4 axis and suppress ferroptosis in VSMCs, aiming to prevent the formation of AAA. The gene discussed is PEBP1; the disease is triple-A syndrome.